Bictegravir suits a wide range of people. Where it does not fit, the reason is frequently about the other components of the tablet rather than the bictegravir itself.
Who is excluded by interactions?
Anyone taking rifampicin or rifapentine for tuberculosis, and anyone on a strong enzyme-inducing anticonvulsant such as carbamazepine, phenytoin or phenobarbital. These reduce levels enough that the regimen would not be reliable.
What about kidney impairment?
It is not recommended below a certain level of kidney function, because of the tenofovir alafenamide component. Since the tablet cannot be adjusted, this means switching to a different regimen rather than reducing anything.
What about liver impairment?
Not recommended in severe hepatic impairment, where it has not been adequately studied. Mild to moderate impairment does not require adjustment.
What if you need a different backbone?
This is the practical limitation. Because bictegravir comes only with emtricitabine and tenofovir alafenamide, anyone who cannot take those components cannot take bictegravir at all. Dolutegravir, available separately and in several combinations, is the usual answer.
What about existing integrase resistance?
Significant resistance to the class reduces its activity, and resistance testing determines whether it remains useful. Someone with documented integrase resistance may need a different approach entirely.
What about the metabolic profile?
Not a contraindication and a consideration for anyone with substantial cardiovascular risk or who has gained significant weight on integrase inhibitors previously. Alternatives with a different profile exist and it is reasonable to discuss them.
What about pregnancy?
Data have accumulated and are broadly reassuring, and some guidance still prefers dolutegravir where a longer record exists. Anyone pregnant or planning a pregnancy should discuss it rather than switching or stopping independently.
What about hepatitis B?
Not a reason to avoid it, and often a reason to choose it, since the tablet covers both. What it means is that stopping cannot be casual, because abrupt withdrawal can cause a liver flare.
What about people taking many other medicines?
Generally a good choice rather than a poor one, since the interaction list is short and there is no booster. The main thing to manage is antacid and supplement timing.
What are the alternatives?
Dolutegravir-based regimens, which offer the same class with more flexibility about what accompanies it, including combinations with lamivudine or with abacavir. Other integrase inhibitors including raltegravir. Doravirine or boosted darunavir where the class is unsuitable.
Can you switch away easily?
Yes. Switching between integrase-based regimens is routine and suppression is maintained provided the new regimen is fully active. A decision now is not permanent.
Who decides?
You do, with a clinician. Suitability is a clinical judgement and the choice between suitable options is yours, including on grounds like tablet size, dosing convenience and how a regimen fits your life.
Is a second opinion reasonable?
Entirely. If you have been told bictegravir is your only option, or that you cannot change, asking to discuss it again or to see someone else is a normal part of care rather than a complaint about anyone.
What happens if you have to change?
Switching is routine and suppression is maintained provided the new regimen is fully active. Coming off bictegravir is not a setback and it does not narrow your options later, since most changes are reversible.
What should you bring to the conversation?
What is actually bothering you, in concrete terms, and what you would want instead if it were possible. That produces a more useful discussion than a general sense that something is not right.
Does avoiding it limit you later?
Rarely. Not taking bictegravir now does not rule it out in future, and it does not narrow the options available to you. Regimens are revisited regularly as circumstances change.
What if your circumstances change?
Regimens are revisited. Pregnancy, a new diagnosis, a new medicine, changing kidney function or simply a change in how you live can all make a different option better. Raising it is reasonable rather than difficult.